Spruce Biosciences Inc (SPRB)

$0.53

-0.02

(-3.83%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $0.52
    $0.55
    $0.53
    downward going graph

    1.13%

    Downside

    Day's Volatility :4.71%

    Upside

    3.62%

    downward going graph
  • $0.50
    $5.95
    $0.53
    downward going graph

    5.09%

    Downside

    52 Weeks Volatility :91.55%

    Upside

    91.09%

    downward going graph

Returns

PeriodSpruce Biosciences IncSector (Health Care)Index (Russel 2000)
3 Months
-24.12%
6.4%
0.0%
6 Months
-78.48%
6.0%
0.0%
1 Year
-76.35%
8.5%
0.0%
3 Years
-94.69%
14.6%
-20.8%

Highlights

Market Capitalization
22.5M
Book Value
$1.62
Earnings Per Share (EPS)
-1.12
Wall Street Target Price
2.5
Profit Margin
0.0%
Operating Margin TTM
-631.02%
Return On Assets TTM
-28.36%
Return On Equity TTM
-53.55%
Revenue TTM
10.1M
Revenue Per Share TTM
0.25
Quarterly Revenue Growth YOY
1.9%
Gross Profit TTM
0.0
EBITDA
-51.4M
Diluted Eps TTM
-1.12
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.23
EPS Estimate Next Year
-1.05
EPS Estimate Current Quarter
-0.29
EPS Estimate Next Quarter
-0.27

Analyst Recommendation

Buy
    53%Buy
    46%Hold
    0
    0%Sell
Based on 13 Wall street analysts offering stock ratings for Spruce Biosciences Inc(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
11
Hold
6
6
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 371.7%

Current $0.53
Target $2.50

Technicals Summary

Sell

Neutral

Buy

Spruce Biosciences Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Spruce Biosciences Inc
Spruce Biosciences Inc
2.46%
-78.48%
-76.35%
-94.69%
-96.91%
Moderna, Inc.
Moderna, Inc.
-9.19%
21.5%
-4.18%
-62.27%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
0.99%
12.81%
44.78%
82.21%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-7.34%
24.69%
58.81%
196.23%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.88%
11.69%
35.62%
150.46%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Spruce Biosciences Inc
Spruce Biosciences Inc
NA
NA
NA
-1.23
-0.54
-0.28
NA
1.62
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Spruce Biosciences Inc
Spruce Biosciences Inc
Buy
$22.5M
-96.91%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Spruce Biosciences Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 58.8% return, outperforming this stock by 135.1%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 196.2% return, outperforming this stock by 290.9%

Institutional Holdings

  • RiverVest Venture Management LLC

    7.13%
  • The Carlyle Group Inc

    7.04%
  • Rock Springs Capital Management LP

    6.34%
  • Rosalind Advisors, Inc.

    3.67%
  • Aisling Capital Management LP

    2.93%
  • Altium Capital Management, LP

    2.79%

Company Information

spruce biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system.

Organization
Spruce Biosciences Inc
Employees
22
CEO
Mr. Michael G. Grey
Industry
Commercial Services

FAQs